CTTI and FDA Convene Workshop on Including Patient Perspectives in Clinical Trials

CTTI and FDA Convene Workshop on Including Patient Perspectives in Clinical Trials

[yoast-breadcrumb]

CTTI Project: Patient Group Engagement

The Clinical Trials Transformation Initiative (CTTI) will convene a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials," in collaboration with the U.S. Food and Drug Administration (FDA) on Mon., March 18, from 9:00 a.m. to 5:00 p.m. at the Tommy Douglas Conference Center in Silver Spring, Md.

PDF icon Download Press Release (262.53 KB)